Jeff Boyle

Mr. Boyle is Vice President of Investor Relations and is responsible for leading investor relations strategy and liaising with the investor community, including sell-side and buy-side analysts, industry analysts, and investors worldwide.

Prior to joining Arvinas, Mr. Boyle spent nearly five years at Sage Therapeutics where he led the development and execution of an integrated investor relations and communications strategy, most recently as Vice President of Investor Relations.

Mr. Boyle has more than 15 years of demonstrated communications and investor relations experience in the biotechnology industry, including previous roles of increasing responsibility at BIND Therapeutics and Biogen. Mr. Boyle began his career at Hill and Knowlton, a global public relations and corporate communications firm.

Mr. Boyle holds a B.A. in finance from the University of Colorado.